Skip to Main Content

Author Details

Loris De Cecco
Fondazione IRCCS Istituto Nazionale dei Tumori
2000
153
35
PMIDPaper TitleJournal TitlePublished Year
37949350Tumor molecular landscape of Epstein-Barr virus (EBV) related nasopharyngeal carcinoma in EBV-endemic and non-endemic areas: Implications for improving treatment modalities.Transl Res2024
36726208Peritoneal fluid COVID-19 testing in patients with a negative nasopharyngeal swab: prospective study.Br J Surg2023
37745365A clinicogenomic model including GARD predicts outcome for radiation treated patients with HPV+ oropharyngeal squamous cell carcinoma.medRxiv2023
37867524Genomic and transcriptomic analyses of thyroid cancers identify DICER1 somatic mutations in adult follicular-patterned RAS-like tumors.Front Endocrinol (Lausanne)2023
35708347A homogeneous treatment for non-DIPG diffuse midline glioma.Tumori2023
37393630A three-gene signature marks the time to locoregional recurrence in luminal-like breast cancer.ESMO Open2023
37326761Optimizing reirradiation for relapsed medulloblastoma: identifying the ideal patient and tumor profiles.J Neurooncol2023
37455307MRI-based radiomic prognostic signature for locally advanced oral cavity squamous cell carcinoma: development, testing and comparison with genomic prognostic signatures.Biomark Res2023
37448520Case report: biallelic <i>DNMT3A</i> mutations in acute myeloid leukemia.Front Oncol2023
37041632Biological and clinical impact of membrane EGFR expression in a subgroup of OC patients from the phase IV ovarian cancer MITO-16A/MANGO-OV2A trial.J Exp Clin Cancer Res2023
37338505A pilot exome sequencing study suggests that germline variants influence methotrexate-induced toxicities in pediatric patients with localized osteosarcoma.Pediatr Blood Cancer2023
37129948BRCA2 Germline Mutations Identify Gastric Cancers Responsive to PARP Inhibitors.Cancer Res2023
36867680JMJD6 Shapes a Pro-tumor Microenvironment via ANXA1-Dependent Macrophage Polarization in Breast Cancer.Mol Cancer Res2023
36565918Reduction of Staphylococcus epidermidis in the mammary tumor microbiota induces antitumor immunity and decreases breast cancer aggressiveness.Cancer Lett2023
34816585The TRAR gene classifier to predict response to neoadjuvant therapy in HER2-positive and ER-positive breast cancer patients: an explorative analysis from the NeoSphere trial.Mol Oncol2022
35643181Genetic Layout of Melanoma Lesions Is Associated with BRAF/MEK-Targeted Therapy Resistance and Transcriptional Profiles.J Invest Dermatol2022
35454858Medullary Thyroid Carcinoma Mutational Spectrum Update and Signaling-Type Inference by Transcriptional Profiles: Literature Meta-Analysis and Study of Tumor Samples.Cancers (Basel)2022
35561166hacksig: a unified and tidy R framework to easily compute gene expression signature scores.Bioinformatics2022
36555441The Educational Program of Macrophages toward a Hyperprogressive Disease-Related Phenotype Is Orchestrated by Tumor-Derived Extracellular Vesicles.Int J Mol Sci2022
36442320Immune-based classification of HPV-associated oropharyngeal cancer with implications for biomarker-driven treatment de-intensification.EBioMedicine2022
36430468MiR-223 Exclusively Impairs In Vitro Tumor Growth through IGF1R Modulation in Rhabdomyosarcoma of Adolescents and Young Adults.Int J Mol Sci2022
36428742HER2 mRNA Levels, Estrogen Receptor Activity and Susceptibility to Trastuzumab in Primary Breast Cancer.Cancers (Basel)2022
36675955Ovarian Cancer Radiosensitivity: What Have We Understood So Far?Life (Basel)2022
36361537Live or Heat-Killed <i>Lactobacillus rhamnosus</i> Aerosolization Decreases Adenomatous Lung Cancer Development in a Mouse Carcinogen-Induced Tumor Model.Int J Mol Sci2022
36231138An Inflammatory Signature to Predict the Clinical Benefit of First-Line Cetuximab Plus Platinum-Based Chemotherapy in Recurrent/Metastatic Head and Neck Cancer.Cells2022
35928879A Cross-Comparison of High-Throughput Platforms for Circulating MicroRNA Quantification, Agreement in Risk Classification, and Biomarker Discovery in Non-Small Cell Lung Cancer.Front Oncol2022
36284197Gene expression-based dissection of inter-histotypes, intra-histotype and intra-tumor heterogeneity in pediatric tumors.Sci Rep2022
36077842A microRNA Prognostic Signature in Patients with Diffuse Intrinsic Pontine Gliomas through Non-Invasive Liquid Biopsy.Cancers (Basel)2022
34922264Validation of MiROvaR, a microRNA-based predictor of early relapse in early stage epithelial ovarian cancer as a new strategy to optimise patients' prognostic assessment.Eur J Cancer2022
34921525What if the future of HER2-positive breast cancer patients was written in miRNAs? An exploratory analysis from NeoALTTO study.Cancer Med2022
35121395Biological properties of hypoxia-related gene expression models/signatures on clinical benefit of anti-EGFR treatment in two head and neck cancer window-of-opportunity trials.Oral Oncol2022
35087134Copy number alterations analysis of primary tumor tissue and circulating tumor cells from patients with early-stage triple negative breast cancer.Sci Rep2022
35083153Complete Response to Nivolumab in Recurrent/Metastatic HPV-Positive Head and Neck Squamous Cell Carcinoma Patient After Progressive Multifocal Leukoencephalopathy: A Case Report.Front Oncol2022
33390181Choline kinase alpha impairment overcomes TRAIL resistance in ovarian cancer cells.J Exp Clin Cancer Res2021
33743331Blood-based genomics of triple-negative breast cancer progression in patients treated with neoadjuvant chemotherapy.ESMO Open2021
33483370Gut Microbiota Condition the Therapeutic Efficacy of Trastuzumab in HER2-Positive Breast Cancer.Cancer Res2021
33751795Complexity index in sarcoma and genomic grade index gene signatures in rhabdomyosarcoma of pediatric and adult ages.Pediatr Blood Cancer2021
33801595Prognostic Evidence of the miRNA-Based Ovarian Cancer Signature MiROvaR in Independent Datasets.Cancers (Basel)2021
33801186SARS-CoV-2 Serology Monitoring of a Cancer Center Staff in the Pandemic Most Infected Italian Region.Cancers (Basel)2021
34738049Clinical Validity of a Prognostic Gene Expression Cluster-Based Model in Human Papillomavirus-Positive Oropharyngeal Carcinoma.JCO Precis Oncol2021
34439180Circulating miRNAs as Novel Non-Invasive Biomarkers to Aid the Early Diagnosis of Suspicious Breast Lesions for Which Biopsy Is Recommended.Cancers (Basel)2021
34548320Integrated Molecular and Immune Phenotype of HER2-Positive Breast Cancer and Response to Neoadjuvant Therapy: A NeoALTTO Exploratory Analysis.Clin Cancer Res2021
34573422Genetic Variants and Somatic Alterations Associated with MITF-E318K Germline Mutation in Melanoma Patients.Genes (Basel)2021
34185403Integrated transcriptional-phenotypic analysis captures systemic immunomodulation following antiangiogenic therapy in renal cell carcinoma patients.Clin Transl Med2021
34072194BRAF Inhibitors Induce Feedback Activation of RAS Pathway in Thyroid Cancer Cells.Int J Mol Sci2021
34142027SPARC regulation of PMN clearance protects from pristane-induced lupus and rheumatoid arthritis.iScience2021
34001010Immunotherapy for the prevention of high-risk oral disorders malignant transformation: the IMPEDE trial.BMC Cancer2021
33373728Transmission of SARS-CoV-2 in Surgical Smoke during Laparoscopy: A Prospective, Proof-of-concept Study.J Minim Invasive Gynecol2021
33107152Development of a multiomics database for personalized prognostic forecasting in head and neck cancer: The Big Data to Decide EU Project.Head Neck2021
33211282AKR1C3 is a biomarker and druggable target for oropharyngeal tumors.Cell Oncol (Dordr)2021
  • 1 - 50 of 153

Recommended Authors

Yuexin Liu
The University of Texas MD Anderson Cancer Center
Career Start Year 2011
Number of shared co-authors 9
Cristina Ivan
The University of Texas MD Anderson Cancer Center
Career Start Year 2010
Number of shared co-authors 5
Jeff P Bruce
Princess Margaret Cancer Centre, University Health Network
Career Start Year 2010
Number of shared co-authors 1
Darragh G McArt
Queen's University Belfast
Career Start Year 2009
Number of shared co-authors 1
Ganiraju C Manyam
the University of Texas MD Anderson Cancer Center
Career Start Year 2009
Number of shared co-authors 1
Karolina Edlund
Leibniz Research Centre for Working Environment and Human Factors at TU Dortmund
Career Start Year 2008
Number of shared co-authors 0
Sander R van Hooff
Princess Maxima Center for Pediatric Oncology
Career Start Year 2008
Number of shared co-authors 2
Gabriele Zoppoli
University of Genoa and Ospedale Policlinico San Martino
Career Start Year 2008
Number of shared co-authors 1
Yang Xie
Quantitative Biomedical Research Center
Career Start Year 2007
Number of shared co-authors 0
Matti Nykter
Prostate Cancer Research Center, Tampere University and Tays Cancer Center
Career Start Year 2006
Number of shared co-authors 8
Pichai Raman
Center for Data-Driven Discovery in Biomedicine, Children's Hospital of Philadelphia
Career Start Year 2006
Number of shared co-authors 1
Tuan Zea Tan
Cancer Science Institute of Singapore, National University of Singapore
Career Start Year 2005
Number of shared co-authors 3
Joshy George
Peter MacCallum Cancer Centre
Career Start Year 2005
Number of shared co-authors 3
Nehad M Alajez
College of Health and Life Sciences, Hamad Bin Khalifa University, Qatar Foundation
Career Start Year 2004
Number of shared co-authors 1
Benjamin Haibe-Kains
Princess Margaret Cancer Centre, University Health Network
Career Start Year 2004
Number of shared co-authors 5
Katherine A Hoadley
Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill
Career Start Year 2004
Number of shared co-authors 3
Lixia Diao
The University of Texas MD Anderson Cancer Center
Career Start Year 2003
Number of shared co-authors 2
Joel S Parker
Lineberger Cancer Center, University of North Carolina
Career Start Year 2002
Number of shared co-authors 5
Ludmila Danilova
Bloomberg-Kimmel Immunotherapy Institute, Johns Hopkins University School of Medicine
Career Start Year 2001
Number of shared co-authors 3
Yidong Chen
The University of Texas Health Science Center at San Antonio
Career Start Year 2001
Number of shared co-authors 0
Darran P O'Connor
UCD Conway Institute, University College Dublin
Career Start Year 2001
Number of shared co-authors 0
Lodewyk F A Wessels
University Medical Centre Mannheim, University of Heidelberg
Career Start Year 2000
Number of shared co-authors 6
David Neil Hayes
Center for Cancer Research, University of Tennessee Health Science Center
Career Start Year 1999
Number of shared co-authors 6
Francesca M Buffa
University of Oxford
Career Start Year 1998
Number of shared co-authors 4
Benedikt Brors
German Cancer Research Center (DKFZ)
Career Start Year 1997
Number of shared co-authors 2
Ole Christian Lingj??rde
University of Oslo
Career Start Year 1997
Number of shared co-authors 0
Jan Budczies
Institute of Pathology, University Hospital Heidelberg
Career Start Year 1996
Number of shared co-authors 1
Holger S??ltmann
German Cancer Research Center (DKFZ)
Career Start Year 1993
Number of shared co-authors 2
Carlos Caldas
Cancer Research UK Cambridge Institute, University of Cambridge
Career Start Year 1992
Number of shared co-authors 5
John W M Martens
Erasmus Medical Center (MC) Cancer Institute
Career Start Year 1989
Number of shared co-authors 7

Collaborators

Lisa Licitra
Fondazione IRCCS Istituto Nazionale dei Tumori and University of Milan
Co-authored papers 24
Manuela Gariboldi
Co-authored papers 16
Stefano Cavalieri
Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, University of Milan
Co-authored papers 11
Maura Massimino
Fondazione IRCCS Istituto Nazionale dei Tumori
Co-authored papers 10
James F Reid
Co-authored papers 8
Tito Poli
University Hospital of Parma
Co-authored papers 5
Ruud H Brakenhoff
Vrije Universiteit Amsterdam
Co-authored papers 5
Charles R Leemans
Location Vrije Universiteit Amsterdam
Co-authored papers 4
Paolo Radice
Ospedale Circolo e Fondazione Macchi
Co-authored papers 4
Piergiorgio Modena
S. Anna General Hospital
Co-authored papers 4
Frank J P Hoebers
Maastricht University Medical Centre
Co-authored papers 4
Annalisa Trama
Fondazione IRCSS Istituto Nazionale dei Tumori
Co-authored papers 4
Felice Giangaspero
Co-authored papers 3
Siranoush Manoukian
Fondazione IRCCS Istituto Nazionale dei Tumori
Co-authored papers 3
Kathrin Scheckenbach
Heinrich-Heine University
Co-authored papers 3
Bianca Pollo
Co-authored papers 3
Javier Ben??tez
Instituto de Salud Carlos III
Co-authored papers 2
Giuseppe Fico
Universidad Politecnica de Madrid
Co-authored papers 2
Claudio Schneider
Laboratorio Nazionale-Consorzio Interuniversitario per le Biotecnologie
Co-authored papers 2
Raffaele Nunziata
Co-authored papers 2
Ana Osorio
Familial Cancer Clinical Unit, Spanish National Cancer Research Centre
Co-authored papers 2
Alice Dawson
University of Dundee
Co-authored papers 1
Sara Busacca
University of Leicester, Robert Kilpatrick Clinical Sciences Building
Co-authored papers 1
Eitan Prisman
University of British Columbia
Co-authored papers 1
Catherine F Poh
University of British Columbia
Co-authored papers 1
Sarah E B Ryan
University of Western Ontario
Co-authored papers 1
Mushfiq H Shaikh
University of Western Ontario
Co-authored papers 1
Mar??a J Garc??a
Spanish National Cancer Research Centre (CNIO)
Co-authored papers 1
David L Rimm
Yale University School of Medicine
Co-authored papers 1
Christopher J Howlett
Western University
Co-authored papers 1
Release 1.2